C07D 295/22
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo
Official title: with hetero atoms directly attached to ring nitrogen atoms
C07D295/22 (Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo) appears on 1,078 US grants and 977 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,078
- Published applications
- 977
- Assignees
- 581
- Inventors
- 3,552
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 17 | 0 |
| 1978 | 11 | 0 |
| 1979 | 17 | 0 |
| 1980 | 11 | 0 |
| 1981 | 11 | 0 |
| 1982 | 11 | 0 |
| 1983 | 9 | 0 |
| 1984 | 13 | 0 |
| 1985 | 10 | 0 |
| 1986 | 13 | 0 |
| 1987 | 13 | 0 |
| 1988 | 10 | 0 |
| 1989 | 10 | 0 |
| 1990 | 10 | 0 |
| 1991 | 8 | 0 |
| 1992 | 11 | 0 |
| 1993 | 13 | 0 |
| 1994 | 25 | 0 |
| 1995 | 14 | 0 |
| 1996 | 26 | 0 |
| 1997 | 25 | 0 |
| 1998 | 26 | 0 |
| 1999 | 24 | 0 |
| 2000 | 26 | 0 |
| 2001 | 18 | 3 |
| 2002 | 33 | 36 |
| 2003 | 33 | 54 |
| 2004 | 19 | 57 |
| 2005 | 25 | 58 |
| 2006 | 30 | 55 |
| 2007 | 25 | 42 |
| 2008 | 22 | 41 |
| 2009 | 29 | 47 |
| 2010 | 31 | 61 |
| 2011 | 27 | 30 |
| 2012 | 31 | 41 |
| 2013 | 50 | 33 |
| 2014 | 38 | 54 |
| 2015 | 46 | 46 |
| 2016 | 37 | 49 |
| 2017 | 46 | 38 |
| 2018 | 25 | 25 |
| 2019 | 25 | 28 |
| 2020 | 16 | 30 |
| 2021 | 24 | 19 |
| 2022 | 12 | 21 |
| 2023 | 13 | 29 |
| 2024 | 10 | 31 |
| 2025 | 16 | 22 |
| 2026 | 10 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Aminimide compound, aminimide composition, curing agent, epoxy resin composition, method for producing aminimide compound, encapsulant, and adhesive6 Oct 2026US 12,753,157 B2Asahi Kasei Kabushiki Kaisha
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Process for the preparation of sulfamoylbenzoic acid derivatives1 Oct 2026US 2026/0297022 A1Iama Therapeutics S.R.L.
- Antibiotics comprising lpxh-targeting compounds and methods of making and using the same24 Sep 2026US 2026/0285808 A1Duke University
- A method of treating seeds and seeds produced thereby13 Aug 2026US 2026/0231848 A1Cyprus University of Technology
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
Most cited
By later US patents
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors218US 5,861,510 APfizer Inc. · 1999
- Methods for generating high titer helper-free preparations of released recombinant AAV vectors183US 6,566,118 B1Targeted Genetics Corporation · 2003
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997